Study of BCX7353 as a Treatment for Attacks of Hereditary Angioedema

PHASE2CompletedINTERVENTIONAL
Enrollment

58

Participants

Timeline

Start Date

July 31, 2017

Primary Completion Date

January 29, 2019

Study Completion Date

January 29, 2019

Conditions
Hereditary Angioedema (HAE)
Interventions
DRUG

BCX7353

oral liquid formulation

DRUG

Placebo

oral liquid formulation to match BCX7353

Trial Locations (24)

Unknown

Study Center, Graz

Study Center, Odense

Study Center, Grenoble

Study Center, Lille

Study Center, Berlin

Study Center, Frankfurt

Study Center, Budapest

Study Center, Ashkelon

Study Center, Tel Aviv

Study Center, Tel Litwinsky

Study Center, Milan

Study center, Padua

Study Center, Salerno

Study Center, Skopje

Study Center, Krakow

Study Center, Târgu Mureş

Study Center, Zurich

Study Center, Birmingham

Study Center, Bristol

Study Center, Cambridge

Study Center, London

Study Center, Manchester

Study Center, Plymouth

Study Center, Southampton

Sponsors
All Listed Sponsors
lead

BioCryst Pharmaceuticals

INDUSTRY